All Type of News
242 reference drugs designated for bio-equivalency tests.
The KFDA started to review the drugs for its bio equivalency from this month, and released the total 242 reference drugs of 60 different ingredients including Zantac under "the reference drugs to prove of bio-equivale...
Pharmaceutical Society to review future new drug R&D.
The Pharmaceutical Society of Korea plans to have an annual conference under the title of "The present and future of new drug development" at Vexco in Busan for 2 days from April 16 by delivering presentations by more...
KFDA to ease preparation for drug registration data .
The dossiers for drug registrations will be eased in the future. The KFDA provides a cyber educational programs for the drug company who wishes to get the drug efficacy and safety review.
The KFDA will disclose suc...
Hospitalized patients to get 80% saving from meals.
Effective from June 1, this year the hospitalized patients may save their expenses for hospital meals by 80% in maximum out of the current prices.
The MOHW took the NHI Policy Review Council on April 10 and decided...
KFDA charged 73 drug companies on unlawful sales.
Gyeongin regional KFDA released an illegal drug distribution finding in the 1st quarter this year that 35 products of Hanmi and 34 products of Taejun were directly sold to hospitals as a top company in number of produ...
MOHW to disclose new drug pricing system plan.
The MOHW announced to disclose a new drug price system plan called "Positive system" some time in May.
In the meeting with the KPMA on April 5, the Insurance and Pension Policy Division of MOHW said that the positi...
Prof. Kim to nominate a head of multinational clinical study.
Prof. Kim Seon-woo of Sungkyunkwan Univ. Medical College Kangbuk Samsung hospital, was nominated as the chief of the multinational clinical studies (145 centers from 8 countries including Korea and the United States) ...
Industry saying "no supply problem" over KFDA's measures.
Recent KFDA's measures against the illegal drug distribution facts has raised concerns about possible drug supply shortage problems because of many products to suspend their sales for one or 3 months, a relevant indus...
KFDA's measures causing unified distribution system to abolish
The drug company directly dealt with hospitals was administratively measured by the KFDA on April 10, however, its aftermath may trigger the industry with a movement of abolishing the unified drug distribution system....
Pfizer Korea partly to recall Novarsc on package error.
Pfizer Korea said on April 5 that a small quantity of Novarsc 5mg, 500 tablet glass bottle (Lot No. 3390 05395 and shelf life up to June 26, 2008) found uncompleted bottle package finishing and the company decided to ...
